Lexicon Pharmaceuticals (LXRX) Fails to deliver data

Key failure to deliver metrics for Lexicon Pharmaceuticals :

• Last SEC data release: 2024-10-31
• Last 15 days FTD volume: £0.21 M
• Last 3 months FTD volume: £2.68 M
• Last year FTD volume: £2.68 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Lexicon Pharmaceuticals (LXRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Lexicon Pharmaceuticals (LXRX) - since 2015

Lexicon Pharmaceuticals (LXRX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Eterna Therapeutics ERNA	£0.06 M	£0.2 M	🇺🇸 USA
Regeneron Pharmaceuticals REGN	£14.63 M	£0.10 B	🇺🇸 USA
Ultragenyx RARE	£0.76 M	£6.92 M	🇺🇸 USA
BioMarin Pharmaceutical BMRN	£4.17 M	£17.05 M	🇺🇸 USA
Thermo Fisher Scientific TMO	£6.82 M	£0.28 B	🇺🇸 USA
Esperion Therapeutics ESPR	£3.02 M	£16.2 M	🇺🇸 USA
Illumina ILMN	£43.22 M	£71.6 M	🇺🇸 USA
Ligand Pharmaceuticals LGND	£7.87 M	£9.91 M	🇺🇸 USA
Aerie Pharmaceuticals AERI	N/A	£0.94 M	🇺🇸 USA